Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Fortrea Holdings Inc. (FTRE : NSDQ)

• Company Description    Fortrea Holdings Inc. is a provider of clinical development and patient access solutions to the life sciences industry. It provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea Holdings Inc. is based in DURHAM, N.C. Number of Employees: 15,500

• Price / Volume Information    Yesterday's Closing Price: $10.10 Daily Weekly Monthly 20 Day Moving Average: 1,858,287 shares Shares Outstanding: 90.80 (millions) Market Capitalization: $917.08 (millions) Beta: 1.91 52 Week High: $25.28 52 Week Low: $3.97 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 27.85% 25.60% 12 Week 85.32% 68.34% Year To Date -45.84% -51.03%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8 MOORE DRIVE - DURHAM,NC 27709 USA ph: 877-495-0816 fax: - investors@fortrea.com http://www.fortrea.com

• General Corporate Information    Officers Thomas Pike - Chief Executive Officer;President and Chairman Jill McConnell - Chief Financial Officer Robert Parks - Chief Accounting Officer Peter M. Neupert - Director Edward Pesicka - Director Peer Information Fortrea Holdings Inc. (CORR.) Fortrea Holdings Inc. (RSPI) Fortrea Holdings Inc. (CGXP) Fortrea Holdings Inc. (BGEN) Fortrea Holdings Inc. (GTBP) Fortrea Holdings Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 34965K107 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/14/25 Share - Related Items Shares Outstanding: 90.80 Most Recent Split Date: (:1) Beta: 1.91 Market Capitalization: $917.08 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.15 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.52 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/14/25

• Fundamental Ratios P/E Current FY Estimate: 19.58 Trailing 12 Months: 16.29 PEG Ratio: - Price Ratios Price/Book: 1.55 Price/Cash Flow: 6.43 Price / Sales: 0.34 EPS Growth vs. Year Ago Period: 733.33% vs. Previous Quarter: 850.00% Sales Growth vs. Year Ago Period: 7.23% vs. Previous Quarter: 9.06% ROE 06/30/25 - 5.25 03/31/25 - 2.84 12/31/24 - 2.13 ROA 06/30/25 - 1.72 03/31/25 - 1.06 12/31/24 - 0.84 Current Ratio 06/30/25 - 1.02 03/31/25 - 0.97 12/31/24 - 1.00 Quick Ratio 06/30/25 - 1.02 03/31/25 - 0.97 12/31/24 - 1.00 Operating Margin 06/30/25 - 2.08 03/31/25 - 1.37 12/31/24 - 1.17 Net Margin 06/30/25 - -37.57 03/31/25 - -29.43 12/31/24 - -12.25 Pre-Tax Margin 06/30/25 - -37.66 03/31/25 - -27.83 12/31/24 - -10.20 Book Value 06/30/25 - 6.51 03/31/25 - 9.49 12/31/24 - 15.19 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - 1.87 03/31/25 - 1.22 12/31/24 - 0.77 Debt-to-Capital 06/30/25 - 65.14 03/31/25 - 55.01 12/31/24 - 43.52

Powered by Zacks Investment Research ©